Elise Langenkamp

Innovations in studying in vivo cell behavior and pharmacology in complex tissues – microvascular endothelial cells in the spotlight

H. Struijker‐Boudier, E. Verpoorte, R. Bischoff, 2013, Cell and Tissue Research.

Tumor Vascular Morphology Undergoes Dramatic Changes during Outgrowth of B16 Melanoma While Proangiogenic Gene Expression Remains Unchanged

H. Hammes, J. Schouten, Elise Langenkamp, 2011, ISRN oncology.

University of Groningen Empirical validation of a rat in vitro organ slice model as a tool for in vivo clearance prediction de Graaf, IAM; de Kanter,

G. Groothuis, Elise Langenkamp, R. Kanter, 2006 .

Innovations in studying in vivo cell behavior and pharmacology in complex tissues – microvascular endothelial cells in the spotlight

H. Struijker‐Boudier, E. Verpoorte, R. Bischoff, 2013, Cell and Tissue Research.

VEGF suppresses T‐lymphocyte infiltration in the tumor microenvironment through inhibition of NF‐κB‐induced endothelial activation

Elise Langenkamp, L. Dieterich, J. Kreuger, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF‐A and TGFβ2 in vascular abnormalization

H. Augustin, F. Pontén, P. Georgii‐Hemming, 2012, The Journal of pathology.

Identification of epigenetically silenced genes in tumor endothelial cells.

J. Herman, M. van Engeland, A. Griffioen, 2007, Cancer research.

Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer

Elise Langenkamp, G. Molema, 2008, Cell and Tissue Research.

Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.

F. Pontén, M. Essand, Elise Langenkamp, 2015, Cancer research.

Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296

Elise Langenkamp, G. Molema, P. Zwiers, 2012, Anti-cancer drugs.

Molecular characterization of tumor vascular phenotype and pharmacology of antiangiogenic therapy

Elise Langenkamp, 2010 .

EMPIRICAL VALIDATION OF A RAT IN VITRO ORGAN SLICE MODEL AS A TOOL FOR IN VIVO CLEARANCE PREDICTION

R. de Kanter, M. D. de Jager, I. A. D. de Graaf, 2006, Drug Metabolism and Disposition.